CYT_AUSSU
ID CYT_AUSSU Reviewed; 141 AA.
AC E3P6N3;
DT 24-JUL-2013, integrated into UniProtKB/Swiss-Prot.
DT 11-JAN-2011, sequence version 1.
DT 03-AUG-2022, entry version 30.
DE RecName: Full=AsCystatin;
DE Short=AsCys;
DE Short=Cystatin;
DE Flags: Precursor;
OS Austrelaps superbus (Lowland copperhead snake) (Hoplocephalus superbus).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC Serpentes; Colubroidea; Elapidae; Acanthophiinae; Austrelaps.
OX NCBI_TaxID=29156;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, LEVEL OF PROTEIN EXPRESSION,
RP 3D-STRUCTURE MODELING IN COMPLEX WITH A CYSTEINE PROTEASE, AND MUTAGENESIS
RP OF GLY-29.
RC TISSUE=Venom, and Venom gland;
RX PubMed=21172403; DOI=10.1016/j.biochi.2010.12.008;
RA Richards R., St Pierre L., Trabi M., Johnson L.A., de Jersey J.,
RA Masci P.P., Lavin M.F.;
RT "Cloning and characterisation of novel cystatins from elapid snake venom
RT glands.";
RL Biochimie 93:659-668(2011).
CC -!- FUNCTION: Recombinant AsCystatin inhibits various C1 cysteine proteases
CC including cathepsin L (Ki is 0.89 pM), papain (Ki is 1.74 pM) and
CC cathepsin B (Ki is 0.69 nM). This activity has also been observed in
CC the crude venom. This protein has no toxic activity and its function in
CC the venom is unknown. It may play a role as a housekeeping or
CC regulatory protein. {ECO:0000269|PubMed:21172403}.
CC -!- SUBCELLULAR LOCATION: Secreted.
CC -!- TISSUE SPECIFICITY: Expressed at a low level by the venom gland (at
CC protein level). {ECO:0000305|PubMed:21172403}.
CC -!- MISCELLANEOUS: The recombinant protein does not inhibit calpain-1
CC (CAPN1), a C2 family cysteine protease and legumain (LGMN), a C13
CC family cysteine protease. Does not provoke cell death (PC3 prostate
CC cancer cells) following continuous exposure to 6 uM for 24 hours
CC (PubMed:21172403). {ECO:0000305|PubMed:21172403}.
CC -!- SIMILARITY: Belongs to the cystatin family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; FJ411278; ACR83839.1; -; mRNA.
DR AlphaFoldDB; E3P6N3; -.
DR SMR; E3P6N3; -.
DR MEROPS; I25.012; -.
DR PRIDE; E3P6N3; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR CDD; cd00042; CY; 1.
DR InterPro; IPR000010; Cystatin_dom.
DR InterPro; IPR046350; Cystatin_sf.
DR Pfam; PF00031; Cystatin; 1.
DR SMART; SM00043; CY; 1.
DR SUPFAM; SSF54403; SSF54403; 1.
PE 1: Evidence at protein level;
KW Disulfide bond; Protease inhibitor; Secreted; Signal;
KW Thiol protease inhibitor.
FT SIGNAL 1..26
FT /evidence="ECO:0000250"
FT CHAIN 27..141
FT /note="AsCystatin"
FT /id="PRO_5000654409"
FT DOMAIN 29..129
FT /note="Cystatin"
FT MOTIF 73..77
FT /note="Secondary area of contact"
FT /evidence="ECO:0000250"
FT SITE 29
FT /note="Reactive site"
FT /evidence="ECO:0000250"
FT DISULFID 91..107
FT /evidence="ECO:0000250"
FT DISULFID 120..140
FT /evidence="ECO:0000250"
FT MUTAGEN 29
FT /note="G->S: 1000-fold reduction in inhibitory activity
FT tested on papain."
FT /evidence="ECO:0000269|PubMed:21172403"
SQ SEQUENCE 141 AA; 15855 MW; 42CC622B56FF34F0 CRC64;
MVHSQLPVAA PLRLLCALLL LPLATMIPGG LSPRSVTDPD VQEAAEFAVQ EYNALSANAY
YYKQLRIVEA QSQVVTGAKY YLTMELMKTK CAKTTGKPKV YKEIQNCELP PKAQQEKLTC
RFQVWSCPWL QKIELTKMSC N